# Noble Pharma, LLC – FDA Inspection, Aug 22, 2025

Source: https://www.keypedia.com/records/fda_inspections/noble-pharma-llc/9bd6b29d-79d2-4833-b195-e984fb7eadfb
Source feed: FDA_Inspections

> FDA inspection 1280216 of Noble Pharma, LLC, August 22, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1280216
- Company Name: Noble Pharma, LLC
- Inspection Date: 2025-08-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Pre-Approval Evaluation of Animal Drugs and Food Additives
- Product Type: Animal Drugs & Feeds
- Center: Animal Drugs & Feeds
- Office Name: Minneapolis District Office
- Citation Count: 1

## Related Documents

- [FDA Inspection 1265315 - 2025-03-06](https://www.keypedia.com/records/fda_inspections/noble-pharma-llc/4923f155-0033-4862-abb1-444168dc5f5c)
- [FDA Inspection 1254963 - 2024-10-24](https://www.keypedia.com/records/fda_inspections/noble-pharma-llc/e9a96dd0-5a11-4598-9b63-6a8e73ed0792)
- FDA Inspection 1116273 - 2019-12-18

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/elizabeth-r-bloom/51c7ec4e-97bb-4543-adc3-cf02d335f159)
- [Issuing Officer](https://www.keypedia.com/people/gurpreet-k-gran/83791ba8-2834-4350-8825-1c4a95bf2e90)
- [FDA Associated Person](https://www.keypedia.com/people/matthew-b-casale/e78481c6-5fbd-4723-a79c-167176395af8)
- [Issuing Officer](https://www.keypedia.com/people/supreet-k-sran/1dab51f8-b483-4ccb-8b44-89fdc3b8100b)

Company: https://www.keypedia.com/companies/noble-pharma-llc/7fd1f37f-ba04-49a3-a115-ad7110e9f8a5

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d
